Passa al contenuto
Merck
Tutte le immagini(4)

Documenti

911879

Sigma-Aldrich

NanoFabTx microfluidic - micro

device kit for synthesis of 10-30 μm particles

Sinonimo/i:

Microfluidic kit, Microparticle, NanoFabTx device kit, Nanoformulation

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali


About This Item

Codice UNSPSC:
12162002
Codice UNSPSC:
41121811

Descrizione

Microfludic device kit for synthesizing 10-30 μm microparticles

Kit components :

  • Microfluidic chip x 1
  • Tubings and accessories

Livello qualitativo

applicazioni

advanced drug delivery

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Descrizione generale

NanoFabTx Microfluidic - micro device kit is designed to work with the NanoFabTx - micro reagent kits like (Cat. No. 912212) for the synthesis of 10-30 μm particles. The device kit includes a comprehensive protocol, pre-assembled microfluidic chip manifold, tubing, and required accessories and is compatible with either the Dolomite microfluidics system or a standard syringe pump (compatible microfluidics system or syringe pump required separately).

Applicazioni

NanoFabTx Microfluidic - micro device kit in combination with the NanoFabTx - micro reagent kits (Cat. No. 912212) can be used to create drug-encapsulating polymeric microparticles 10-30 μm in size. Because of the adjustable flow rate, small reaction window, and adjustable concentrations, microfluidic-based synthesis is a powerful tool for fabricating size-controlled particles to encapsulate drugs, small molecules, mRNA, DNA, and proteins. The chip geometries and flow parameters enable facile, scalable synthesis of monodispersed particles with consistent size and drug loading to facilitate rapid formulation screening.

Caratteristiche e vantaggi

  • Simplifies polymer chemistry of microfluidic formulation development for enhancing drug bioavailability
  • Accelerates optimization of drug encapsulation and loading efficiency in microparticles
  • Provides step-by-step microfluidic-based protocols developed and tested by our formulation scientists
  • Minimizes waste of expensive reagents

Note legali

NANOFABTX is a trademark of Sigma-Aldrich Co. LLC

Certificati d'analisi (COA)

Cerca il Certificati d'analisi (COA) digitando il numero di lotto/batch corrispondente. I numeri di lotto o di batch sono stampati sull'etichetta dei prodotti dopo la parola ‘Lotto’ o ‘Batch’.

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

Andrew Gdowski et al.
Journal of nanobiotechnology, 16(1), 12-12 (2018-02-13)
The process of optimization and fabrication of nanoparticle synthesis for preclinical studies can be challenging and time consuming. Traditional small scale laboratory synthesis techniques suffer from batch to batch variability. Additionally, the parameters used in the original formulation must be
Xuanyu Li et al.
Advanced drug delivery reviews, 128, 101-114 (2017-12-27)
Microfluidic chips allow the rapid production of a library of nanoparticles (NPs) with distinct properties by changing the precursors and the flow rates, significantly decreasing the time for screening optimal formulation as carriers for drug delivery compared to conventional methods.
Samar Damiati et al.
Genes, 9(2) (2018-02-22)
Microfluidic devices present unique advantages for the development of efficient drug carrier particles, cell-free protein synthesis systems, and rapid techniques for direct drug screening. Compared to bulk methods, by efficiently controlling the geometries of the fabricated chip and the flow

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.